What does CDKI stand for?

Cyclin-Dependent Kinase Inhibitor

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Cyclin Dependent Kinase 6 Cyclin-Dependent Kinase 7 (human gene) Cyclin-Dependent Kinase 8 Cyclin Dependent Kinase 9 Cyclin Dependent Kinase Chief Dull Knife College (Lame Deer, MT) Center for Diabetic Kidney Disease (Thomas Jefferson Hospital; Philadelphia, PA) Cyclin-Dependent Kinase D1 (genetics) Carolinas District Kiwanis Foundation (Columbia, SC) Central Difference Kalman Filter		Cyclin-Dependent Kinase Inhibitor Proteins Cyclin-Dependent Kinase Like Cyclin-dependent Kinase-like 3 Cyclin-Dependent Kinase-Like 5 (gene) Community-Driven Knowledge Management Cyclin-Dependent Kinase Inhibitor Cyclic AMP (Adenosine Monophosphate)-Dependent Kinase Number 2 Centrum Doskonalenia Kadr Oswiatowych (Polish: Personnel Center of Excellence; Poland) Cambridge Disabled Kids Swimming Club (UK) C. D. Leet (early ammunition headstamp)

Samples in periodicals archive:

EXPERIMENTAL DESIGN: HCC cells were treated with vitamin K2 and the expression of several growth-related genes including cyclin-dependent kinase inhibitors and cyclin D1 was examined at the mRNA and protein levels.

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular ...

14) p27 is regarded as a cyclin-dependent kinase inhibitor of the G1-to-S cell cycle progression by suppressing the kinase activity of cyclin/cyclin-dependent kinase complex.

Cell cycle alterations in endometrial carcinoma

5) suggest that genes up-regulated in parathyroid adenoma are those responsible for blood vessel angiogenesis and genes belonging to the cyclin-dependent kinase inhibitor groups.

Differential expression of kinase genes in primary ...

p16, The Cyclin-Dependent Kinase Inhibitor in Prostate Cancer By Cheryl T.

p16, The Cyclin-Dependent Kinase Inhibitor in Prostate Cancer

kip1]: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.

Multiparameter Immunohistochemical Analysis of the Cell Cycle ...

mtm's CINtec(TM) technology is based on detecting over-expression of p16INK4a, a cyclin-dependent kinase inhibitor and the first objective cellular marker with tremendous potential for clinical application in screening and diagnosis of HPV-induced cancers, such as cervical cancer.

mtm Laboratories Announces Granting of US Patent Covering Its CINtec